Cocrystal Pharma appoints James Sapirstein as Chief Executive Officer
Cocrystal Pharma announced the appointment of James Sapirstein as Chief Executive Officer effective June 3, 2026, with a $265,000 annual salary and 235,000 stock options. The leadership change signals organizational transition and provides equity incentive alignment with company performance.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day